Selective cyclooxygenase-2 inhibitors for the treatment of arthritis
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (7) , 1131-1157
- https://doi.org/10.1016/s0149-2918(00)80018-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cyclo-Oxygenase IsoenzymesDrugs, 1997
- The Clinical Implications of Inhibition of the Inducible Form of Cyclo-OxygenaseDrug Safety, 1996
- Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort studyArchives of internal medicine (1960), 1996
- Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysisBMJ, 1996
- CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal TractGastroenterology Clinics of North America, 1996
- Guidelines for monitoring drug therapy in rheumatoid arthritisArthritis & Rheumatism, 1996
- Safety of Meloxicam: A Global Analysis of Clinical TrialsRheumatology, 1996
- Distinct isoforms (COX‐1 and COX‐2) of cyclooxygenase: possible physiological and therapeutic implicationsFundamental & Clinical Pharmacology, 1996
- Mechanism of Action of Anti-Inflammatory DrugsScandinavian Journal of Rheumatology, 1996
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995